Analysts/Institutional Investor Meet/Con. Call Updates

3 November 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543064 Scrip Symbol: COHANCE Dear Sir/Madam, Sub: Revised Schedule of Conference Call for Investors and Analysts This is with reference to our intimation dated 27 October 2026 regarding the conference call with investors and analysts. Please note that the timing of the conference call has been revised from 6:30 p.m. (IST) to 6:00 p.m. (IST). Please find enclosed the revised intimation for the conference call scheduled to be held on Friday, 6 November 2026 at 6:00 P.M. (IST) to discuss the Unaudited Financial Results of the Company for the Quarter and Half-year ended 30 September 2026 (Q2 and H1 FY27), which will be announced earlier on the same day. Kindly take the above on record. Thanking You. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K. Mishra Company Secretary & Compliance Officer Cohance Lifesciences Limited’s Q2 and H1FY27 Results Conference Call on Friday, November 06, 2026 at 6.00 pm IST The senior management of Cohance Lifesciences Ltd. will participate in a Conference Call for investors and analysts to be hosted by the Company on Friday, November 06, 2026, at 6.00 pm IST. The conference call will be initiated with a brief management discussion on the Q2 & H1FY27 results to be declared earlier in the day followed by an interactive Question & Answer session. Details of the conference call are as follows: Time and date 6.00 pm IST on Friday, November 06, 2026 Conference dial-in Primary number +91 22 6280 1141 / +91 22 7115 8042 Singapore Toll Free Number 800 101 2045 Hong Kong Toll Free Number 800 964 448 USA Toll Free Number 1 866 746 2133 UK Toll Free Number 0 808 101 1573 To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Pre-registration You will receive dial in numbers, passcode and a pin for the concall on the registered email address provided by you. Kindly dial into the call on the Conference Call date and use the passcode & pin to connect to call Please dial the above number 5-10 minutes prior to the scheduled start to ensure that you are connected to the call on time. For more information, please contact: Cyndrella Carvalho, Head - Investor Relations, Gavin Desa / Konpal Pali Cohance Lifesciences Limited CDR India Tel: 040 2354 3311 Tel: +91 98206 37649 / +91 76619 08341 Email: cyndrella.carvalho@cohance.com Email: gavin@cdr-india.com / konpal@cdr-india.com Q2 FY27 Concall Invite